![](/wp-content/uploads/2018/10/phEAsTU8R9yBQYRCp6V4.png)
$599
Lexicon @ Stifel; First Presentation Since SOLOIST and SCORED Results
Lexicon participated in the 2020 Stifel Virtual Healthcare Conference and provided brief updates on its sotagliflozin strategy following the data readout from SOLOIST and SCORED. In case you missed it, here is a link to FENIX’s initial thoughts on the data. Below, FENIX provides highlights from Lexicon senior management’s commentary as well as an updated perspective and implications to sotagliflozin’s commercial prospects.